Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    - No significant changes detected in the study details between the two screenshots. The core content, including study title, objectives, eligibility criteria, interventions, and outcomes, appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T00:58:19.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    43 days ago
    Change Detected
    Summary
    - Add: government funding notice, new topic on diffuse large B-cell lymphoma, and version bump to v3.2.0; - Remove: old version tag v3.1.0.
    Difference
    2%
    Check dated 2025-10-05T09:18:39.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Upgraded to v3.1.0 by removing the topic 'Diffuse large B-cell lymphoma' from resources and keeping the version label as the primary change.
    Difference
    0.2%
    Check dated 2025-09-28T03:08:17.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated to v3.0.2, replacing the previous v3.0.1. The 'Back to Top' element was removed.
    Difference
    0.1%
    Check dated 2025-09-13T16:39:04.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-06T14:08:02.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and a revised facility name and location, while removing previous details about certain drugs and related topics. Notably, the addition of specific drugs like cyclophosphamide and fludarabine enhances the core content related to treatment options for diffuse large B-cell lymphoma.
    Difference
    4%
    Check dated 2025-08-30T11:07:11.000Z thumbnail image

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.